EKIMAS Corporation (ASNB)
Stock analysis · OTC · Financial Services · Shell Companies
EKIMAS Corporation (ASNB) is a publicly traded company in the Financial Services sector. Latest price: $0.85. Market cap $4.83M. Trailing PE -3.04. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About EKIMAS Corporation
Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues. The firm's current objective is to identify, acquire, or combine with an existing operating entity through an equity-for-equity transaction. Established in 1993, this Las Vegas, Nevada-based entity was formerly known as AdvanSource Biomaterials Corporation, changing its name to EKIMAS Corporation in March 2020.
Valuation
| P/E (TTM) | -3.04× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | 0.26× |
| PEG | 0.06× |
| P/FCF (TTM) | -1.18× |
| EV / EBITDA | -1.39× |
| EV / Sales | 0.00× |
| Earnings Yield | 7.42% |
| Free Cash Flow Yield | -84.60% |
Fundamentals
| Enterprise Value | $4.91M |
|---|---|
| Net Income (TTM) | $358.09K |
| Free Cash Flow (TTM) | -$4.08M |
| Net Debt | $76.22K |
| Working Capital | -$1.37M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 1.89% |
| Return on Invested Capital | 1.43% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap